# PRecisiOn Medicine In StrokE: Evolution of Plasma Brain-Derived Tau in Acute Stroke

> **NCT06121336** · — · RECRUITING · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 100 (estimated)

## Conditions studied

- Stroke
- Stroke, Acute
- Stroke, Ischemic
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Brain Ischemia
- Nervous System Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Plasma levels of BD-tau

## Key facts

- **NCT ID:** NCT06121336
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06121336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06121336, "PRecisiOn Medicine In StrokE: Evolution of Plasma Brain-Derived Tau in Acute Stroke". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06121336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*